Back to Results
First PageMeta Content
Medicine / Overactive bladder / Solifenacin / Urinary incontinence / Urinary retention / Percutaneous tibial nerve stimulation / Duloxetine / Muscarinic antagonists / Chemistry / Organic chemistry


Media Contact: Christy Nolandofficemobile) Investor Contact:
Add to Reading List

Document Date: 2015-05-17 18:16:46


Open Document

File Size: 513,48 KB

Share Result on Facebook

City

TOKYO / NEW ORLEANS / Bristol / /

Company

Abrams P. Worldwide / Facebook / Astellas Pharma Inc. / Twitter / /

Country

United Kingdom / /

/

Facility

Bristol Urological Institute / University of Bristol / /

IndustryTerm

pharmaceuticals / treatment of overactive bladder with symptoms / heavy machinery / pharmaceutical / /

MedicalCondition

intestinal obstruction / overactive bladder / hypertension / headache / narrow-angle glaucoma / Urinary retention / nasopharyngitis / urinary tract infection / urinary incontinence / hallucinations / bladder outlet obstruction / urge urinary incontinence / Bladder (OAB) Overactive bladder / uncontrolled narrow-angle glaucoma / Angioedema / suspected hypersensitivity / incontinent overactive bladder / Anaphylactic reactions / hypersensitivity / fecal impaction / constipation / angioneurotic edema / /

Organization

international continence society / American Urological Association / /

Person

Marcus Drake / Christy Noland / /

/

Position

Professor / /

Product

VESIcare / MIRA / ketoconazole / /

URL

www.astellas.us / www.twitter.com/AstellasUS / http /

SocialTag